Sign inJoin waitlistJoin the waitlist

TS

Turcin Saridogan

Credentials:

History

Residency
2023–2026
Medical School
2019–2023

Research

Oxidative Phosphorylation Is a Metabolic Vulnerability in Chemotherapy-Resistant Triple-Negative Breast Cancer
Cancer Research · 2021 · 142 citations
Combining Neratinib with CDK4/6, mTOR, and MEK Inhibitors in Models of HER2-positive Cancer
Clinical Cancer Research · 2021 · 55 citations
Efficacy of futibatinib, an irreversible fibroblast growth factor receptor inhibitor, in FGFR-altered breast cancer
Scientific Reports · 2023 · First of 16 authors · 17 citations

IS
Ibrahim Sahin
7 papers
AS
Anwaar Saeed
4 papers
Funda Meric-Bernstam
4 papers
Christian Pico
3 papers · 3 as a resident
Stephen Scott
3 papers
VG
Vikram Gorantla
3 papers
Aatur Singhi
2 papers
Arvind Dasari
2 papers
DH
Dennis Hsu
2 papers
JZ
Janie Zhang
2 papers
MS
Masood Pasha Syed
2 papers · 2 as a fellow
MM
Monica Malhotra
2 papers